| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |